Finally, since PCYOX1 was not reduced in vitro by both fibrate and statin treatment (Supplementary Fig. 8), our results indicate that PCYOX1 might represent an additional drug target in atherosclerosis. The gene discussed is PCYOX1; the disease is atherosclerosis.